Volume 10, Number 11—November 2004
Public Health Interventions and SARS Spread, 20031
|Flight||Duration||Index patient(s)||No. infected/ no. on plane (%)|
|1||90 min||1 presymptomatic||0/315 (0.0)|
|2||3 h||1 fever, cough||22/120 (18.3)|
|3||90 min||2 fever; 2 fever, cough||1/246 (0.4)|
aSource: ref 19.
- World Health Organization. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS) WHO/CDS/CSR/GAR/2003. [monograph on the Internet] 2003 Oct 11, 17 [cited 2004 Sep 20]. Available from http://www.who.int/csr/sars/en/WHOconsensus.pdf
- WHO Global Conference on Severe Acute Respiratory Syndrome (SARS). 17–18 June 2003. [cited 2004 Sep 20]. Available from http://www.who.int/csr/sars/conference/june_2003/en/
- Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ, Hedley AJ, Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003;300:1961–6.
- Lipsitch M, Cohen C, Cooper B, Robins JM, Ma S, James L, Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003;300:1966–70.
- Pang X, Zhu Z, Xu F, Guo J, Gong X, Liu D, Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003. JAMA. 2003;290:3215–21.
- Svoboda T, Henry B, Shulman L, Kennedy E, Rea E, Ng W, Public health measures to control the spread of the severe acute respiratory syndrome in Toronto. N Engl J Med. 2004;350:2352–61.
- Gostin LO, Bayer R, Fairchild AL. Ethical and legal implications posed by the severe acute respiratory syndrome: implications for the control of severe infectious disease threats. JAMA. 2003;290:3229–37.
- Cetron M, Maloney S, Koppaka R, Simone P. Isolation and quarantine: containment strategies for SARS 2003. In: Knobler S, Mahmoud M, Lemon S, Mack A, Sivitz L, Oberholtzer K, editors. Learning from SARS: preparing for the next disease outbreak. Forum on microbial threats, board of health. Institute of Medicine of the National Academies. Washington: National Academies Press; 2004. p. 71–83.
- Lee ML, Chen CJ, Su IJ, Chen KT, Yeh CC, King CC, Use of quarantine to prevent transmission of severe acute respiratory syndrome- Taiwan, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:680–3.
- Lai CKL. Hong Kong Department of Health. Presentation at Symposium on Rethinking Quarantines: New Considerations for “Old Medicine.” Center for Strategic and International Studies. Washington, D.C. Sep17, 2003.
- Ou J, Li Q, Zeng G, Dun Z, Qin A, Fontaine RE. Efficiency of quarantine during an epidemic of severe acute respiratory syndrome in Beijing, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:1037–40.
- Blendon RJ, Benson JM, DesRoches CM, Raleigh E, Taylor-Clark K. The public’s reaction to severe acute respiratory syndrome in Toronto and the United States. Clin Infect Dis. 2004;38:925–31.
- Hawryluck L, Gold WL, Robinson S, Pogorski S, Galea S, Styra R, SARS control and psychological effects of quarantine, Toronto, Canada. Emerg Infect Dis. 2004;7:1206–12.
- Kaydos-Daniels SC, Olowokure B, Chang HJ, Barwick RS, Deng JF, Lee ML, Body temperature monitoring and SARS fever hotline, Taiwan. Emerg Infect Dis. 2004;10:373–6.
- Wu J, Xu F, Zhou W, Feikin DR, Lin CY, He X, Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerg Infect Dis. 2004;10:210–6.
- Lau JTF, Tsui H, Lau M, Yang X. SARS transmission, risk factors, and prevention in Hong Kong. Emerg Infect Dis. 2004;10:587–92.
- Yu ITS, Li Y, Wong TW, Tam W, Chan AT, Lee JHW, Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med. 2004;350:1731–9.
- Update 11—WHO recommends new measures to prevent travel-related spread of SARS. Geneva. [cited 2003 Mar 27]. Available from http://www.who.int/csr/sars/archive/2003_03_27/en/
- Olsen SJ, Chang HL, Cheung TYY, Tang AFY, Fisk TL, Ooi SPL, et al. Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med. 2003;349:2416–22.
- Desenclos JC, Van der Werf S, Bonmarin I, Levy-Bruhl D, Yazdanpanah Y, Hoen B, Introduction of SARS in France, March–April, 2003. Emerg Infect Dis. 2004;10:195–200.
- Wilder-Smith A, Paton NI, Goh KT. Low risk of transmission of severe acute respiratory syndrome on airplanes: the Singapore experience. Trop Med Int Health. 2003;8:1035–7.
- Breugelmans JG, Zucs P, Porten K, Broll S, Niedrig M, Ammon A, SARS transmission and commercial aircraft. Emerg Infect Dis. 2004;10:1502–3.
- Flint J, Burton S, Macey JF, Deeks SL, Tam TWS, King A, Assessment of in-flight transmission of SARS-results of contact tracing, Canada. Can Commun Dis Rep. 2003;29:105–10.
- Moser MR, Bender TR, Margolis HS, Noble GR, Kendal AP, Ritter G. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol. 1979;110:1–6.
- Kenyon TA, Valway SE, Ihle WW, Onorato IM, Castro KG. Transmission of multiudrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med. 1996;334:933–8.
- World Health Organization. China’s latest SARS outbreak has been contained, but biosafety concerns remain—update 7. [cited 2004 May 18]. http://www.who.int/csr/don/2004_05_18a/en/
- World Health Organization. WHO consultation on priority public health interventions before and during an influenza pandemic. Geneva. [cited 2004 Mar 16–18]. Available from http://www.who.int/csr/disease/avian_influenza/consultation/en/
- World Health Organization Scientific Research Advisory Committee on Severe Acute Respiratory Syndrome (SARS). Report of the first meeting, Geneva, Switzerland, 20–21 Oct 2003. WHO/CDS/CSR/GAR/2004.16. [cited 2004 Sep 20]. Available from http://www.who.int/csr/resources/publications/WHO_CDS_CSR_GAR_2004_16/en/
1The members of the World Health Organization (WHO) Working Group are as follows: Ximena Aguilera, Ministerio de Salud, Republica de Chile; Roy Anderson, Imperial College London, United Kingdom; Dounia Bitar, Institut de Veille Sanitaire, Paris France; Martin Cetron (with Pattie Simone), Centers for Disease Control and Prevention, Atlanta, Georgia, USA; Chew Suok Kai (with Benjamin KW Koh), Ministry of Health, Singapore; Clete DiGiovanni, Jr., Defense Threat Reduction Agency, Fort Belvoir, Virginia, USA; Arlene King, Health Canada, Ottawa, Canada; Cindy K-L Lai (with PL Ma), Department of Health, Hong Kong Special Administrative Region, China; Angus Nicoll (with Jane Leese), Communicable Disease Surveillance Centre, London, United Kingdom; Sonja Olsen, International Emerging Infections Program, Nonthaburi, Thailand; Alice Sarradet, Direction Generale de la Sante, Paris, France; Mingchang Song, General Administration of Quality Supervision, Inspection and Quarantine, (AQSIQ), Beijing, China; Ron St. John (with Susan Courage), Health Canada, Ottawa, Canada; Robert Steffen (with Leonie Prasad), University of Zurich, Switzerland; Ih-Jen Su (with SK Lai), Taiwan Center for Disease Control, Taipei, Taiwan, China; WHO Staff in the Department of Communicable Diseases Surveillance and Response (CSR): Julie Hall, Beijing, China; Emmanuel Jesuthasan, Geneva, Switzerland; Angela Merianos, Cathy Roth, Max Hardiman, Geneva, Switzerland; Hitoshi Oshitani, Western Pacific Regional Office, Manila, Philippines; and group facilitator: David Bell, WHO (CSR) Geneva, Switzerland, and Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
2The term “isolation” is applied to ill people; “quarantine” is applied to persons who have been exposed but are not ill.